01.06.
2022
The GLA is very happy to announce two support programs of our cooperation partner SPARK,
SPARK-BIH Program 2022
Scientists and clinicians of all career stages at Charité including BIH can apply for the SPARK-BIH program 2022 with their translational projects in the fields of drug development (small molecule, biologics, ATMP, gene therapy, repurposing), medical device technology and diagnostics in all medical fields. SPARK-BIH supports projects with funding, mentoring, coaching and targeted education for a period of 12-24 months.
Proposals can be submitted until July 4th, 2022 (14:00 CET).
Further information: SPARK-BIH Program 2022
Neurocure/SPARK Program 2022
Scientists and clinicians from the NeuroCure network at all career levels are invited to submit translational project for the Neurocure/SPARK program 2022. NeuroCure/SPARK supports the development of novel therapeutics (small molecules, biologics, ATMP, gene therapy), medical devices and diagnostics as well as the repurposing of existing drugs for new indications and digital health projects. NeuroCure/SPARK empowers project teams to overcome translational hurdles through education, mentoring, expert advice, dedicated funding and entrepreneurship support. Funding can be granted for up to 50.000€ for one year. Applications need to be co-signed by a NeuroCure PI who will hold financial responsibility.
Applications are accepted until July 4th, 2022 (14:00 CET).
Further information: Neurocure/SPARK Program 2022
Please help us spread the word and inform colleagues!
